CVS Caremark Will Cover Eli Lilly’s Zepbound Weight Loss Drug Again Starting October 2026 Here Is What Changes for Patients
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday. Zepbound will return to CVS Caremark’s formulary by October 1, and some patients with private insurance could pay as little as a $25 copay. The reversal…
